Potential target for multiple sclerosis therapy discovered
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...
Why weak-binding M–N–C catalysts defy expectations in oxygen reduction reactions
A new study has challenged conventional wisdom on oxygen reduction reaction (ORR) catalysts by uncovering a novel reaction ...
UroToday6h
ASCO GU 2025: Case-Based Session: Failure of Immunotherapy in Renal Cell Cancer – What’s Next
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to a case-based session ...
The Hilltop21h
Howard receives top research classification, marking milestone for HBCUs
Howard regained Research One status through the American Council of Education after previously losing the classification in ...